Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer

BACKGROUND: While localized prostate cancer (PCa) can be effectively cured, metastatic disease inevitably progresses to a lethal state called castration-resistant prostate cancer (CRPC). Emerging evidence suggests that aberrant epigenetic repression by the polycomb group (PcG) complexes fuels PCa pr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Epigenetics
Asıl Yazarlar: Clermont, Pier-Luc, Crea, Francesco, Chiang, Yan Ting, Lin, Dong, Zhang, Amy, Wang, James Z. L., Parolia, Abhijit, Wu, Rebecca, Xue, Hui, Wang, Yuwei, Ding, Jiarui, Thu, Kelsie L., Lam, Wan L., Shah, Sohrab P., Collins, Colin C., Wang, Yuzhuo, Helgason, Cheryl D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751702/
https://ncbi.nlm.nih.gov/pubmed/26877821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-016-0182-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller